Zomedica Pharmaceuticals Corp (ZOM)

Jan 7, 2025, 6:30 AM EST - 10 days ago

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market

Dec 23, 2024, 6:30 AM EST - 25 days ago

Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone

Dec 19, 2024, 6:30 AM EST - 4 weeks ago

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

Nov 27, 2024, 6:30 AM EST - 7 weeks ago

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024

Nov 14, 2024, 6:30 AM EST - 2 months ago

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Nov 12, 2024, 6:30 AM EST - 2 months ago

Noble Capital Markets Initiates Equity Research Coverage on Zomedica

Nov 8, 2024, 6:30 AM EST - 2 months ago

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024

Nov 7, 2024, 8:43 PM EST - 2 months ago

Zomedica Corp. (ZOM) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:25 PM EST - 2 months ago

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth

Oct 24, 2024, 6:30 AM EDT - 3 months ago

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform

Oct 23, 2024, 7:20 PM EDT - 3 months ago

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET

Oct 15, 2024, 6:30 AM EDT - 3 months ago

Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference

Oct 3, 2024, 6:30 AM EDT - 3 months ago

Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

Sep 11, 2024, 6:30 AM EDT - 4 months ago

Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota

Sep 5, 2024, 6:30 AM EDT - 4 months ago

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

Aug 29, 2024, 6:30 AM EDT - 5 months ago

Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product

Aug 22, 2024, 6:30 AM EDT - 5 months ago

Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System

Aug 21, 2024, 9:12 AM EDT - 5 months ago

More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively Buying

NRDY AEI

Aug 20, 2024, 6:30 AM EDT - 5 months ago

Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference

Aug 14, 2024, 7:58 PM EDT - 5 months ago

Zomedica Corp. (ZOM) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 5 months ago

Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth

Aug 14, 2024, 6:30 AM EDT - 5 months ago

Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America

Aug 1, 2024, 6:30 AM EDT - 6 months ago

Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET

Jul 17, 2024, 6:30 AM EDT - 6 months ago

The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEA

Jul 9, 2024, 6:30 AM EDT - 6 months ago

Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets

Jul 1, 2024, 6:30 AM EDT - 7 months ago

US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians

Jun 27, 2024, 6:30 AM EDT - 7 months ago

Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform

Jun 25, 2024, 6:30 AM EDT - 7 months ago

Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark

Jun 10, 2024, 6:30 AM EDT - 7 months ago

Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024

Jun 6, 2024, 6:30 AM EDT - 8 months ago

Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference

Jun 4, 2024, 6:30 AM EDT - 8 months ago

Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels

May 15, 2024, 6:30 AM EDT - 8 months ago

Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform

May 9, 2024, 8:11 PM EDT - 9 months ago

Zomedica Corp. (ZOM) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:15 PM EDT - 9 months ago

Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity

May 8, 2024, 6:30 AM EDT - 9 months ago

Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024

May 6, 2024, 6:30 AM EDT - 9 months ago

Zomedica Expands International Reach with CE Certification for VetGuardian(R) System

May 2, 2024, 6:30 AM EDT - 9 months ago

Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform

Apr 30, 2024, 6:30 AM EDT - 9 months ago

Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET

Apr 9, 2024, 6:30 AM EDT - 10 months ago

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

Apr 1, 2024, 8:49 PM EDT - 10 months ago

Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 4:05 PM EDT - 10 months ago

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

Mar 20, 2024, 6:30 AM EDT - 10 months ago

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET

Mar 14, 2024, 6:30 AM EDT - 11 months ago

Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform

Mar 13, 2024, 4:45 PM EDT - 11 months ago

Zomedica Provides NYSE American Listing Update

Mar 12, 2024, 6:30 AM EDT - 11 months ago

Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences

Mar 7, 2024, 6:30 AM EST - 11 months ago

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

Mar 5, 2024, 6:30 AM EST - 11 months ago

Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024

Feb 8, 2024, 6:30 AM EST - 1 year ago

Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences

Feb 6, 2024, 4:30 PM EST - 1 year ago

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)

Feb 6, 2024, 6:30 AM EST - 1 year ago

Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET